Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection

Arifa S. Khan, Dominick A. Vacante, Jean-Pol Cassart, Siemon H. S. Ng, Christophe Lambert, Robert L. Charlebois and Kathryn E. King
PDA Journal of Pharmaceutical Science and Technology November 2016, 70 (6) 591-595; DOI: https://doi.org/10.5731/pdajpst.2016.007161
Arifa S. Khan
1Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: arifa.khan@fda.hhs.gov dvacante@its.jnj.com
Dominick A. Vacante
2Janssen Research & Development, LLC, Malvern, PA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Pol Cassart
3GlaxoSmithKline Vaccines, Wavre, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Siemon H. S. Ng
4Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Lambert
5GlaxoSmithKline Vaccines, Rixensart, Belgium; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert L. Charlebois
4Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn E. King
6Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 70 no. 6 591-595
DOI 
https://doi.org/10.5731/pdajpst.2016.007161
PubMed 
27593693

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online December 13, 2016.

Article Versions

  • previous version (September 4, 2016 - 12:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2016

Author Information

  1. Arifa S. Khan1,*,
  2. Dominick A. Vacante2,
  3. Jean-Pol Cassart3,
  4. Siemon H. S. Ng4,
  5. Christophe Lambert5,
  6. Robert L. Charlebois4 and
  7. Kathryn E. King6
  1. 1Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD;
  2. 2Janssen Research & Development, LLC, Malvern, PA;
  3. 3GlaxoSmithKline Vaccines, Wavre, Belgium;
  4. 4Analytical Research and Development, Sanofi Pasteur. Toronto, ON, Canada;
  5. 5GlaxoSmithKline Vaccines, Rixensart, Belgium; and
  6. 6Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD
  1. ↵* Corresponding Author: Dr. Arifa S. Khan, Laboratory of Retroviruses, Division of Viral Products, Office of Vaccines Research and Review, CBER/FDA, 10903 New Hampshire Ave, HFM-454, Bldg 52-72, Room 1216, Silver Spring, MD 20993 USA; e-mail: arifa.khan{at}fda.hhs.gov. Dr. Dominick Vacante, Janssen Research & Development, LLC, 200 Great Valley Parkway, Malvern, PA 19355; e-mail: dvacante{at}its.jnj.com.
View Full Text

Cited By...

  • 21 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • A Reference Viral Database (RVDB) To Enhance Bioinformatics Analysis of High-Throughput Sequencing for Novel Virus Detection
    Norman Goodacre, Aisha Aljanahi, Subhiksha Nandakumar, Mike Mikailov, Arifa S. Khan, Michael J. Imperiale, Eric Delwart, David Wang
    mSphere 2018 3 2
  • Viral contamination in biologic manufacture and implications for emerging therapies
    Paul W. Barone, Michael E. Wiebe, James C. Leung, Islam T. M. Hussein, Flora J. Keumurian, James Bouressa, Audrey Brussel, Dayue Chen, Ming Chong, Houman Dehghani, Lionel Gerentes, James Gilbert, Dan Gold, Robert Kiss, Thomas R. Kreil, René Labatut, Yuling Li, Jürgen Müllberg, Laurent Mallet, Christian Menzel, Mark Moody, Serge Monpoeho, Marie Murphy, Mark Plavsic, Nathan J. Roth, David Roush, Michael Ruffing, Richard Schicho, Richard Snyder, Daniel Stark, Chun Zhang, Jacqueline Wolfrum, Anthony J. Sinskey, Stacy L. Springs
    Nature Biotechnology 2020 38 5
  • The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing
    Adam C. Fisher, Mark-Henry Kamga, Cyrus Agarabi, Kurt Brorson, Sau L. Lee, Seongkyu Yoon
    Trends in Biotechnology 2019 37 3
  • Current Perspectives on High-Throughput Sequencing (HTS) for Adventitious Virus Detection: Upstream Sample Processing and Library Preparation
    Siemon Ng, Cassandra Braxton, Marc Eloit, Szi Feng, Romain Fragnoud, Laurent Mallet, Edward Mee, Sarmitha Sathiamoorthy, Olivier Vandeputte, Arifa Khan
    Viruses 2018 10 10
  • Reshaping cell line development and CMC strategy for fast responses to pandemic outbreak
    Zheng Zhang, Ji Chen, Junghao Wang, Qiao Gao, Zhujun Ma, Shurong Xu, Li Zhang, Jill Cai, Weichang Zhou
    Biotechnology Progress 2021 37 5
  • A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection
    Arifa S. Khan, Siemon H. S. Ng, Olivier Vandeputte, Aisha Aljanahi, Avisek Deyati, Jean-Pol Cassart, Robert L. Charlebois, Lanyn P. Taliaferro, Katherine McMahon
    mSphere 2017 2 5
  • Sensitivity and breadth of detection of high-throughput sequencing for adventitious virus detection
    Robert L. Charlebois, Sarmitha Sathiamoorthy, Carine Logvinoff, Lucy Gisonni-Lex, Laurent Mallet, Siemon H. S. Ng
    npj Vaccines 2020 5 1
  • Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection
    Christophe Lambert, Cassandra Braxton, Robert L. Charlebois, Avisek Deyati, Paul Duncan, Fabio La Neve, Heather D. Malicki, Sebastien Ribrioux, Daniel K. Rozelle, Brandye Michaels, Wenping Sun, Zhihui Yang, Arifa S. Khan
    Viruses 2018 10 10
  • Report of the second international conference on next generation sequencing for adventitious virus detection in biologics for humans and animals
    Arifa S. Khan, Johannes Blümel, Dieter Deforce, Marion F. Gruber, Carmen Jungbäck, Ivana Knezevic, Laurent Mallet, David Mackay, Jelle Matthijnssens, Maureen O'Leary, Sebastiaan Theuns, Joseph Victoria, Pieter Neels
    Biologicals 2020 67
  • Report of the international conference on next generation sequencing for adventitious virus detection in biologicals
    Arifa S. Khan, Luca Benetti, Johannes Blumel, Dieter Deforce, William M. Egan, Ivana Knezevic, Philip R. Krause, Laurent Mallet, Dietmar Mayer, Philip D. Minor, Pieter Neels, Guanhua Wang
    Biologicals 2018 55
  • Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing
    Megan H. Cleveland, Bharathi Anekella, Michael Brewer, Pei-Ju Chin, Heather Couch, Eric Delwart, Jim Huggett, Scott Jackson, Javier Martin, Serge Monpoeho, Tom Morrison, Siemon H.S. Ng, David Ussery, Arifa S. Khan
    Biologicals 2020 64
  • Integrated viral clearance strategies — reflecting on the present, projecting to the future
    David J Roush
    Current Opinion in Biotechnology 2018 53
  • Historical evaluation of the in vivo adventitious virus test and its potential for replacement with next generation sequencing (NGS)
    Paul W. Barone, Flora J. Keumurian, Caleb Neufeld, Andrea Koenigsberg, Robert Kiss, James Leung, Michael Wiebe, Rima Ait-Belkacem, Chakameh Azimpour Tabrizi, Cristina Barbirato, Pascale Beurdeley, Audrey Brussel, Jean-Pol Cassart, Colette Cote, Noémie Deneyer, Veera Dheenadhayalan, Leyla Diaz, Angela Geiselhoeringer, Maria M. Gilleece, Jakob Goldmann, Danielle Hickman, Angela Holden, Björn Keiner, Martina Kopp, Thomas R. Kreil, Christophe Lambert, Carine Logvinoff, Brandye Michaels, Jens Modrof, Brian Mullan, Jürgen Mullberg, Marie Murphy, Sean O'Donnell, José Peña, Michael Ruffing, Horst Ruppach, Nasrin Salehi, Shahjahan Shaid, Lindsey Silva, Richard Snyder, Mélancolie Spedito-Jovial, Olivier Vandeputte, Bernice Westrek, Bin Yang, Ping Yang, Stacy L. Springs
    Biologicals 2023 81
  • Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals
    Arifa S. Khan, Laurent Mallet, Johannes Blümel, Jean-Pol Cassart, Ivana Knezevic, Siemon H.S. Ng, Michael Wall, Miia Jakava-Viljanen, Carine Logvinoff, Ana Goios, Pieter Neels
    Biologicals 2023 83
  • IABS/DCVMN webinar on next generation sequencing
    Arifa S. Khan, Sebastiaan Theuns, Laurent Mallet, Gwenael Cirefice, Ravneet Bhuller, Ana Goios, Rajinder Suri, Pieter Neels
    Biologicals 2023 81
  • Pharmacoepidemiology
    Robert T. Chen, Jason M. Glanz, Tom T. Shimabukuro
    2019
  • Evaluation of next-generation sequencing performance for in vitro detection of viruses in biological products
    Takamasa Hirai, Kiyoko Kataoka, Yuzhe Yuan, Keisuke Yusa, Yoji Sato, Kazuhisa Uchida, Ken Kono
    Biologicals 2024 85
  • Attitude and perception survey for the Japanese pharmaceutical industry to utilize next-generation sequencing for virus safety assessment of biologics
    Ryutaro HIRASAWA, Michiko TAKAKURA, Takamasa HIRAI, Ken KONO, Yoji SATO
    Translational and Regulatory Sciences 2022 4 3
  • Identification of infectious viruses for risk‐based virus testing of CHO unprocessed bulk using next‐generation sequencing
    Tiffany Hsu, Mary Jo Talley, Ping Yang, Angela Geiselhoeringer, Cindy Yang, Aditya Gorla, M. Julhasur Rahman, Lindsey Silva, Dayue Chen, Bin Yang
    Biotechnology Progress 2024 40 6
  • Standards and Metrology for Viral Vectors as Molecular Tools: Outcomes from a CCQM Workshop
    Jonathan J. Campbell, Neil Almond, Young-Kyong Bae, Ravneet Bhuller, Andrea Briones, Sang-Joon Cho, Megan H. Cleveland, Thomas E. Cleveland, Francis Galaway, Hua-Jun He, Ulrike Herbrand, Jim F. Huggett, Sarah Kempster, Ibolya E. Kepiro, Arifa S. Khan, Edward Kwee, Wilson Li, Sheng Lin-Gibson, Luise Luckau, Caterina Minelli, Maxim G. Ryadnov, Isobel Searing, Lili Wang, Alexandra S. Whale, Julian H. Braybrook
    Biologics 2024 4 2
  • Virus detection by short read high throughput sequencing in a high virus low cellular background
    Pei-Ju Chin, Christophe Lambert, Pascale Beurdelay, Robert L. Charlebois, Anne-Sophie Colinet, Marc Eloit, Shanaz Gilchrist, Maria Gilleece, Matthew Hess, Andreas Leimbach, Tom J. B. de Man, Olivier Vandeputte, Dawid Walas, Weihong Wang, Arifa S. Khan
    npj Vaccines 2025 10 1
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 70 (6)
PDA Journal of Pharmaceutical Science and Technology
Vol. 70, Issue 6
November/December 2016
  • Table of Contents
  • Index by Author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
8 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
Arifa S. Khan, Dominick A. Vacante, Jean-Pol Cassart, Siemon H. S. Ng, Christophe Lambert, Robert L. Charlebois, Kathryn E. King
PDA Journal of Pharmaceutical Science and Technology Nov 2016, 70 (6) 591-595; DOI: 10.5731/pdajpst.2016.007161

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection
Arifa S. Khan, Dominick A. Vacante, Jean-Pol Cassart, Siemon H. S. Ng, Christophe Lambert, Robert L. Charlebois, Kathryn E. King
PDA Journal of Pharmaceutical Science and Technology Nov 2016, 70 (6) 591-595; DOI: 10.5731/pdajpst.2016.007161
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Need for Considering New Technologies for Virus Detection
    • Challenges of Using HTS for Virus Detection
    • AVDTIG Efforts
    • AVDTIG Achievements
    • Conflict of Interest Declaration
    • Acknowledgements
    • Reference
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Proceedings of the 2023 Viral Clearance Symposium, Session 8: Cell Banks, Advanced Technologies (ATMPs, NGS)
  • A Reference Viral Database (RVDB) To Enhance Bioinformatics Analysis of High-Throughput Sequencing for Novel Virus Detection
  • A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection
  • Google Scholar

More in this TOC Section

  • A Risk Based Approach for Pre-Use/Post-Sterilization Integrity Test Simulation During Bacterial Retention Testing as Part of the Process Specific Filter Validation of Sterilizing Grade Filters
  • Challenges and Solutions to Manufacturing of Low-Viscosity, Ultra-High Concentration IgG1 Drug Products: From Late Downstream Process to Final Fill Finish Processing
  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
Show more Commentary

Similar Articles

Keywords

  • high throughput sequencing
  • Next Generation Sequencing
  • massively parallel sequencing
  • new technologies
  • virus detection
  • Adventitious viruses

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire